Mayne Pharma Group Ltd (MYX)
Mayne Pharma Group Limited is a specialty pharmaceutical company. The Company is focused on applying its drug delivery to commercialize branded and generic pharmaceuticals. The Company's operating segments are Mayne Pharma International (MPI), US Products (USP) and Metrics Contract Services (MCS). The MPI segment is engaged in manufacture and sale of branded and generic pharmaceutical product and provision of contract manufacturing services to third-party customers within Australia. The USP segment is engaged in the manufacture and distribution of generic and branded pharmaceutical products in the United States. The MCS segment provides contract pharmaceutical development services to third-party customers in the United States. The Company's products include Astrix, Doryx, Eryc, Kadian, Kapanol, Magnoplasm, Lozanoc, SUBA-Itraconazole, ZEBUTAL, ESGIC, ESGIC PLUS, LORCET and LORCET PLUS. The Company also provides contract development and manufacturing services to its clients.